Skip to main content
← All guides

Cancer Treatment Research — CFDA 93.395

$8,755,707,172.30 ($8.8 billion) in federal obligations are recorded for Cancer Treatment Research (CFDA 93.395) in USAspending.gov assistance awards indexed on SpendingVault. The extract lists 3,545 awards, 632 recipients, and 51 states. Those figures are obligations, not outlays and not a count of trials completed

Key figures

  • CFDA 93.395 shows $8,755,707,172.30 in USAspending obligations.
  • 3,545 awards and 632 recipients sit under that total across 51 states.
  • Award volume is high relative to many capital listings of similar dollar size.
  • Figures are obligations from USAspending.gov, not Treasury outlays.

3,545 awards under $8.76 billion

Assistance listing 93.395 is titled CANCER TREATMENT RESEARCH in the USAspending.gov files this site indexes. The obligation total on that code is $8,755,707,172.30. An obligation is a recorded federal commitment on an award. It is not a laboratory invoice already paid.

3,545 awards sit under that dollar book. Dividing $8,755,707,172.30 by 3,545 produces a mean near $2.47 million per award record. That quotient is derived from the two packet totals. It is not a typical clinical-trial budget and not a per-patient research cost. Many research actions can add to $8,755,707,172.30 without any single row dominating the table.

632 organizational recipients appear on those rows. 51 states are coded for place of performance. Neither count converts the obligation total into a headcount of investigators.

632 recipients and 51 states

CFDA 93.395 lists 632 recipients against 3,545 awards. Recipient count is not unique scientists. It is how many organizational recipients the assistance extract stores. One university or cancer center can hold many awards, which is why 3,545 records can sit on 632 recipients.

Fifty-one states is a coded-jurisdiction span. Extra modifications can lift the 3,545-award count while dollars stay near $8,755,707,172.30. The treatment-research hub keeps dollars, awards, recipients, and states visible so one statistic is not inferred from another.

Obligations versus research outlays

USAspending.gov publishes obligations on assistance awards. The $8,755,707,172.30 figure for CFDA 93.395 can include multi-year commitments that will disburse later. A separate institute budget justification or a clinical-trials registry is a different publication. This page does not translate the obligation total into those series.

If a number you expected is missing, the usual cause is a different reporting concept. Start from the obligation definition, then open the 93.395 program page. Do not stretch 3,545 awards to cover every cancer-research dollar tagged under another listing.

What the 93.395 tables omit

The Cancer Treatment Research hub lists award-backed obligations from USAspending.gov. It is not a grant abstract file, not a patient roster, and not a ranking of study quality. Series that never appear as assistance awards will not show up in the $8,755,707,172.30.

Place-of-performance on 51 states is a coding field. A multi-site award coded to one cell can dominate geography while work occurs in several locations. Read the program page before any state split.

How to cite CFDA 93.395

A complete citation is $8,755,707,172.30 in obligations for CFDA 93.395, covering 3,545 awards, 632 recipients, and 51 states, drawn from USAspending.gov assistance awards on SpendingVault. Name the series as obligations. If the question is award volume rather than dollars, lead with 3,545 awards, then the dollar total.

Start with the Cancer Treatment Research program page, then the all-programs index. Agency pages show awarding organizations; they do not replace this listing’s obligation total.

A worked reading of the 93.395 extract

Start from the four packet facts on CFDA 93.395: $8,755,707,172.30 in obligations, 3,545 awards, 632 recipients, and 51 states. The mean near $2.47 million per award is a quotient from those two packet totals, not a typical unit cost and not a household or client rate. If a later USAspending.gov file adds a few large actions, dollars can jump while 632 recipients barely move. If modifications proliferate, 3,545 can rise while the dollar book stays close to $8,755,707,172.30.

Nothing in the extract splits CANCER TREATMENT RESEARCH into subaccounts, fiscal years, or outlay versus obligation series beyond the stored totals. Those cuts live in other publications. Treat CFDA 93.395 as an assistance-listing tag on USAspending.gov award files. Open the program page, then the all-programs index, for a same-series ranking. Cite 3,545 awards and 632 recipients next to the dollars so the record count is visible beside $8,755,707,172.30. Name the series as obligations, not outlays, every time the figure is reused. Agency pages show awarding organizations; they do not replace this listing’s obligation total.

A complete working citation for this listing is $8,755,707,172.30 in USAspending.gov obligations for CFDA 93.395, covering 3,545 awards, 632 recipients, and 51 states, indexed on SpendingVault. Do not convert 3,545 awards into a publication count, or 632 recipients into a scientist roster. The 51-state field is place-of-performance coding in the assistance extract. Read the CANCER TREATMENT RESEARCH hub before inferring a geographic story from the dollar total alone. If a number you expected is missing from $8,755,707,172.30, the usual cause is a different reporting concept rather than a gap in the 3,545 award rows.

Questions

How much is obligated under cancer treatment research?
USAspending.gov assistance awards indexed on SpendingVault show $8,755,707,172.30 in obligations for CFDA 93.395. That sum is an obligation total, not a Treasury outlay total and not a count of papers. The same extract lists 3,545 awards, 632 recipients, and 51 states.
How many awards does CFDA 93.395 have?
The indexed award count is 3,545. Those records carry $8,755,707,172.30 in obligations. The 3,545 figure is a file statistic, not a count of investigators. 632 organizational recipients are stored on those rows. The program hub on SpendingVault holds the award rows behind those totals. Keep the series labeled as obligations from USAspending.gov assistance awards; do not swap in an outlay figure from another report.
Is the $8.76 billion already spent in labs?
Not as a cash-paid sum. USAspending reports obligations—commitments to pay—rather than outlays. The $8,755,707,172.30 figure can include amounts that will disburse later. Cite CFDA 93.395 with the obligation total from USAspending.gov assistance awards, not an outlay series. The program hub on SpendingVault holds the award rows behind those totals. Keep the series labeled as obligations from USAspending.gov assistance awards; do not swap in an outlay figure from another report.
How many states appear on CFDA 93.395?
The extract codes 51 states for Cancer Treatment Research. That count is place-of-performance geography in USAspending.gov assistance files, not a map of every lab. Those rows still sit under the $8,755,707,172.30 obligation total and the 632-recipient count. The program hub on SpendingVault holds the award rows behind those totals. Keep the series labeled as obligations from USAspending.gov assistance awards; do not swap in an outlay figure from another report.

CFDA/Assistance Listing numbers from USAspending assistance awards on SpendingVault.